Drug Type Proteolysis-targeting chimeras |
Synonyms- |
Target |
Mechanism RIPK1 modulators(Receptor-interacting serine/threonine-protein kinase 1 modulators), RIPK2 inhibitors(Serine/threonine-protein kinase RIPK2 inhibitors), Proteolysis |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC43H48N6O11S2 |
InChIKeyBRZGXSNAXRPPFI-UHFFFAOYSA-N |
CAS Registry2089205-64-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | GB | 23 Mar 2017 |